| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 8 | 0 | 0 | 8 |
| phosphopantetheinyl transferase | 15 | 0 | 0 | 15 |
| bromodomain adjacent to zinc finger domain 2B | 9 | 0 | 0 | 9 |
| euchromatic histone-lysine N-methyltransferase 2 | 42 | 0 | 0 | 42 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| geminin | 32 | 0 | 0 | 32 |
| Glycoprotein hormones alpha chain | 2 | 0 | 0 | 2 |
| Guanine nucleotide-binding protein G | 4 | 0 | 0 | 4 |
| Tubulin--tyrosine ligase | 0 | 2 | 0 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 15 | 0 | 0 | 15 |
| Genome polyprotein | 0 | 3 | 1 | 4 |
| USP1 protein, partial | 18 | 0 | 0 | 18 |
| AR protein | 43 | 0 | 0 | 43 |
| thyroid stimulating hormone receptor | 17 | 0 | 0 | 17 |
| glucocorticoid receptor [Homo sapiens] | 31 | 0 | 0 | 31 |
| retinoic acid nuclear receptor alpha variant 1 | 25 | 0 | 0 | 25 |
| estrogen nuclear receptor alpha | 42 | 0 | 0 | 42 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 20 | 0 | 0 | 20 |
| Histone H2A.x | 8 | 0 | 0 | 8 |
| chromobox protein homolog 1 | 21 | 0 | 0 | 21 |
| transcriptional regulator ERG isoform 3 | 5 | 0 | 0 | 5 |
| Polyphenol oxidase 2 | 0 | 2 | 0 | 3 |
| Cellular tumor antigen p53 | 28 | 0 | 0 | 28 |
| Thiopurine S-methyltransferase | 0 | 1 | 0 | 1 |
| Succinate-semialdehyde dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 3 | 0 | 3 |
| Dihydropteroate synthase | 0 | 0 | 1 | 1 |
| Chain A, Toluene-4-monooxygenase system protein A | 0 | 1 | 0 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 19 | 0 | 0 | 19 |
| RGS12 | 1 | 0 | 0 | 1 |
| GLI family zinc finger 3 | 30 | 0 | 0 | 30 |
| estrogen receptor 2 (ER beta) | 15 | 0 | 0 | 15 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 20 | 0 | 0 | 20 |
| vitamin D3 receptor isoform VDRA | 11 | 0 | 0 | 11 |
| thyroid hormone receptor beta isoform 2 | 20 | 0 | 0 | 20 |
| Alpha-synuclein | 6 | 1 | 0 | 7 |
| interleukin 8 | 6 | 0 | 0 | 6 |
| TDP1 protein | 33 | 0 | 0 | 33 |
| progesterone receptor | 20 | 0 | 0 | 20 |
| estrogen-related nuclear receptor alpha | 29 | 0 | 0 | 29 |
| IDH1 | 13 | 0 | 0 | 13 |
| Bloom syndrome protein isoform 1 | 10 | 0 | 0 | 10 |
| ras-related protein Rab-9A | 7 | 0 | 0 | 7 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 23 | 0 | 0 | 23 |
| survival motor neuron protein isoform d | 13 | 0 | 0 | 13 |
| lamin isoform A-delta10 | 31 | 0 | 0 | 31 |
| ATP-binding cassette sub-family C member 3 | 0 | 30 | 0 | 30 |
| Multidrug resistance-associated protein 4 | 0 | 31 | 0 | 35 |
| Voltage-dependent calcium channel gamma-2 subunit | 12 | 0 | 0 | 12 |
| Bile salt export pump | 0 | 42 | 0 | 42 |
| Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
| Glutamate receptor 2 | 12 | 1 | 0 | 13 |
| Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 3 | 2 | 5 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 2 |
| Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 3 | 1 | 5 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
| TAR DNA-binding protein 43 | 10 | 0 | 0 | 10 |
| Canalicular multispecific organic anion transporter 1 | 0 | 30 | 0 | 30 |
| Shiga toxin subunit A | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| peroxisome proliferator activated receptor gamma | 16 | 0 | 0 | 16 |
| Thromboxane-A synthase | 0 | 2 | 0 | 2 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
| Prostacyclin receptor | 0 | 4 | 2 | 6 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 2 | 2 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 4 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 3 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
| ATAD5 protein, partial | 17 | 0 | 0 | 17 |
| Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
| arylsulfatase A | 13 | 0 | 0 | 13 |
| Protein-lysine 6-oxidase | 0 | 1 | 0 | 1 |
| Protein-lysine 6-oxidase | 0 | 1 | 0 | 1 |
| Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
| Lysyl oxidase homolog 3 | 0 | 1 | 0 | 1 |
| Lysyl oxidase homolog 4 | 0 | 1 | 0 | 1 |
| Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
| glucocerebrosidase | 9 | 0 | 0 | 9 |
| DNA polymerase kappa isoform 1 | 10 | 0 | 0 | 10 |
| histone acetyltransferase KAT2A isoform 1 | 9 | 0 | 0 | 9 |
| Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
| Type-1A angiotensin II receptor | 0 | 2 | 1 | 3 |
| Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
| Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
| Type-1 angiotensin II receptor | 0 | 3 | 3 | 6 |
| Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
| Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| thioredoxin reductase | 21 | 0 | 0 | 21 |
| NFKB1 protein, partial | 8 | 0 | 0 | 8 |
| GLS protein | 16 | 0 | 0 | 16 |
| alpha-galactosidase | 3 | 0 | 0 | 3 |
| cytochrome P450 2C19 precursor | 11 | 0 | 0 | 11 |
| flap endonuclease 1 | 11 | 0 | 0 | 11 |
| DNA polymerase iota isoform a (long) | 11 | 0 | 0 | 11 |
| muscarinic acetylcholine receptor M1 | 15 | 0 | 0 | 15 |
| lethal factor (plasmid) | 9 | 0 | 0 | 9 |
| Cytochrome P450 3A4 | 0 | 9 | 0 | 10 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 2 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 13 | 0 | 0 | 13 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 11 | 0 | 0 | 11 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 11 | 0 | 0 | 11 |
| Chain B, HADH2 protein | 11 | 0 | 0 | 11 |
| Chain A, 2-oxoglutarate Oxygenase | 10 | 0 | 0 | 10 |
| GTP-binding protein (rab7) | 0 | 0 | 2 | 2 |
| ras protein, partial | 0 | 0 | 2 | 2 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 18 | 0 | 0 | 18 |
| cytochrome P450 2D6 | 12 | 0 | 0 | 12 |
| peroxisome proliferator-activated receptor delta | 19 | 0 | 0 | 19 |
| Rac1 protein | 0 | 0 | 2 | 2 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 2 | 2 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 7 | 0 | 0 | 7 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 4 | 0 | 4 |
| Prostaglandin G/H synthase 1 | 0 | 5 | 0 | 5 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Epidermal growth factor receptor | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 1 | 0 | 5 | 0 | 7 |
| Carbonic anhydrase 2 | 0 | 5 | 1 | 8 |
| Fatty acid-binding protein, liver | 0 | 3 | 0 | 3 |
| Integrin beta-3 | 6 | 2 | 0 | 8 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 5 | 0 | 5 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 2 | 0 | 2 |
| Integrin alpha-IIb | 6 | 1 | 0 | 7 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 8 | 0 | 8 |
| Adenosine receptor A1 | 0 | 1 | 0 | 2 |
| Adenosine receptor A2a | 0 | 2 | 1 | 4 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 10 | 0 | 10 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 8 | 0 | 0 | 8 |
| Ras-related protein Rab-2A | 0 | 0 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 17 | 2 | 4 | 23 |
| Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 4 |
| Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
| Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 9 | 2 | 11 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 2 | 2 |
| nuclear receptor subfamily 1, group I, member 3 | 25 | 0 | 0 | 25 |
| retinoid X nuclear receptor alpha | 20 | 0 | 0 | 20 |
| pregnane X nuclear receptor | 24 | 0 | 0 | 24 |
| cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 4 | 0 | 0 | 4 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 2 | 2 |
| Solute carrier family 22 member 1 | 0 | 6 | 0 | 8 |
| 5-hydroxytryptamine receptor 4 | 0 | 12 | 0 | 12 |
| Muscarinic acetylcholine receptor M2 | 0 | 5 | 2 | 10 |
| Muscarinic acetylcholine receptor M4 | 0 | 4 | 1 | 7 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M5 | 0 | 4 | 1 | 7 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
| Muscarinic acetylcholine receptor M1 | 0 | 5 | 2 | 10 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 5 | 2 | 9 |
| Alpha-1D adrenergic receptor | 0 | 10 | 3 | 15 |
| 5-hydroxytryptamine receptor 2C | 0 | 12 | 1 | 13 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 10 | 0 | 0 | 11 |
| 5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
| Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
| Chain A, Integrase | 0 | 1 | 0 | 1 |
| Chain A, Integrase | 0 | 1 | 0 | 1 |
| Chain A, T4 LYSOZYME | 0 | 0 | 1 | 1 |
| Chain A, GCN4P1 | 0 | 0 | 1 | 1 |
| Chain B, GCN4P1 | 0 | 0 | 1 | 1 |
| Chain C, GCN4P1 | 0 | 0 | 1 | 1 |
| Chain A, T4 LYSOZYME | 0 | 0 | 1 | 1 |
| Chain A, T4 LYSOZYME | 0 | 0 | 1 | 1 |
| Chain A, Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Chain A, 3C-like proteinase | 0 | 1 | 0 | 1 |
| pregnane X receptor | 13 | 0 | 0 | 13 |
| cellular tumor antigen p53 isoform a | 7 | 0 | 0 | 7 |
| Endolysin | 0 | 0 | 2 | 2 |
| farnesoid X nuclear receptor | 11 | 0 | 0 | 11 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 21 | 0 | 0 | 21 |
| aryl hydrocarbon receptor | 11 | 0 | 0 | 11 |
| nuclear receptor subfamily 1, group I, member 2 | 9 | 0 | 0 | 9 |
| thyroid hormone receptor beta isoform a | 6 | 0 | 0 | 6 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 13 | 0 | 0 | 13 |
| galanin receptor type 3 | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 14 | 2 | 21 |
| Glycine receptor subunit alpha-1 | 0 | 14 | 0 | 14 |
| Glycine receptor subunit beta | 0 | 14 | 0 | 14 |
| Glycine receptor subunit alpha-2 | 0 | 14 | 0 | 14 |
| Glycine receptor subunit alpha-3 | 0 | 14 | 0 | 14 |
| ORF73 | 0 | 0 | 1 | 1 |
| RAR-related orphan receptor gamma | 22 | 0 | 0 | 22 |
| thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
| Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 2 | 1 | 3 |
| Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 16 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 21 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Microtubule-associated protein tau | 10 | 0 | 0 | 10 |
| lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
| D(1A) dopamine receptor | 9 | 0 | 0 | 9 |
| mitogen-activated protein kinase 1 | 13 | 0 | 0 | 13 |
| serine/threonine-protein kinase mTOR isoform 1 | 4 | 0 | 0 | 4 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
| nuclear receptor ROR-gamma isoform 1 | 10 | 0 | 0 | 10 |
| Toll-like receptor 4 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 4 |
| Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 10 | 6 | 16 |
| Aldo-keto reductase family 1 member B1 | 0 | 7 | 0 | 7 |
| ATP-dependent translocase ABCB1 | 0 | 15 | 2 | 29 |
| Beta-1 adrenergic receptor | 0 | 12 | 6 | 18 |
| Alpha-2A adrenergic receptor | 0 | 10 | 4 | 17 |
| Neuronal acetylcholine receptor subunit alpha-4 | 2 | 1 | 0 | 3 |
| Neuronal acetylcholine receptor subunit beta-2 | 2 | 1 | 0 | 3 |
| Angiotensin-converting enzyme | 0 | 8 | 0 | 8 |
| Beta-3 adrenergic receptor | 0 | 8 | 6 | 14 |
| D(2) dopamine receptor | 0 | 5 | 1 | 6 |
| Alpha-2B adrenergic receptor | 0 | 7 | 2 | 12 |
| Alpha-2C adrenergic receptor | 0 | 6 | 4 | 13 |
| 5-hydroxytryptamine receptor 1A | 0 | 14 | 4 | 19 |
| D(1A) dopamine receptor | 0 | 5 | 1 | 6 |
| UDP-glucuronosyltransferase 1A1 | 0 | 4 | 0 | 5 |
| Sodium-dependent noradrenaline transporter | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 2A | 0 | 10 | 1 | 11 |
| 5-hydroxytryptamine receptor 1B | 0 | 12 | 0 | 12 |
| Sodium-dependent serotonin transporter | 0 | 8 | 0 | 8 |
| D(3) dopamine receptor | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 2B | 0 | 12 | 1 | 13 |
| D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
| 5-hydroxytryptamine receptor 6 | 0 | 8 | 1 | 9 |
| Potassium channel subfamily K member 10 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 15 | 0 | 15 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 8 | 0 | 8 |
| Multidrug and toxin extrusion protein 1 | 0 | 5 | 0 | 5 |
| Ataxin-2 | 20 | 0 | 0 | 20 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
| Chain A, Cruzipain | 3 | 0 | 0 | 3 |
| Luciferase | 12 | 0 | 0 | 12 |
| acid sphingomyelinase | 2 | 0 | 0 | 2 |
| acetylcholinesterase | 10 | 0 | 0 | 10 |
| PAX8 | 0 | 0 | 0 | 2 |
| glp-1 receptor, partial | 8 | 0 | 0 | 8 |
| 15-lipoxygenase, partial | 9 | 0 | 0 | 9 |
| hypoxia-inducible factor 1 alpha subunit | 9 | 0 | 0 | 9 |
| SMAD family member 2 | 9 | 0 | 0 | 9 |
| SMAD family member 3 | 9 | 0 | 0 | 9 |
| caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 8 | 0 | 0 | 8 |
| PINK1 | 2 | 0 | 0 | 2 |
| G | 16 | 0 | 0 | 16 |
| 67.9K protein | 9 | 0 | 0 | 9 |
| Parkin | 5 | 0 | 0 | 5 |
| heat shock protein 90 | 0 | 0 | 1 | 1 |
| caspase-3 | 2 | 0 | 0 | 2 |
| calcineurin A1, putative | 0 | 0 | 1 | 1 |
| activating transcription factor 6 | 12 | 0 | 0 | 12 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 10 | 0 | 0 | 10 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 10 | 0 | 0 | 10 |
| cytochrome P450 2D6 isoform 1 | 11 | 0 | 0 | 11 |
| hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9 precursor | 7 | 0 | 0 | 7 |
| perilipin-5 | 0 | 1 | 0 | 1 |
| perilipin-1 | 0 | 1 | 0 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 9 | 0 | 0 | 9 |
| heat shock protein beta-1 | 10 | 0 | 0 | 10 |
| huntingtin isoform 2 | 3 | 0 | 0 | 3 |
| importin subunit beta-1 isoform 1 | 5 | 0 | 0 | 5 |
| ubiquitin-conjugating enzyme E2 N | 0 | 2 | 0 | 2 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| protein AF-9 isoform a | 0 | 0 | 0 | 1 |
| snurportin-1 | 5 | 0 | 0 | 5 |
| melanocortin receptor 4 | 0 | 1 | 0 | 1 |
| CAAX prenyl protease | 0 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
| plasminogen precursor | 4 | 0 | 0 | 4 |
| bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
| peripheral myelin protein 22 | 16 | 0 | 0 | 16 |
| cytochrome P450 3A4 isoform 1 | 17 | 0 | 0 | 17 |
| glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
| hexokinase HKDC1 | 0 | 1 | 0 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 2 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 17 | 1 | 4 | 22 |
| Synaptojanin-2 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 4 | 0 | 0 | 4 |
| Synaptojanin-1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
| Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
| Interferon beta | 22 | 0 | 0 | 22 |
| HLA class I histocompatibility antigen, B alpha chain | 16 | 0 | 0 | 16 |
| 72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 17 | 1 | 4 | 22 |
| Gamma-aminobutyric acid receptor subunit delta | 17 | 1 | 4 | 22 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 17 | 1 | 4 | 22 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 17 | 1 | 4 | 22 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 17 | 1 | 4 | 22 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 17 | 1 | 4 | 22 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 17 | 1 | 4 | 22 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 17 | 1 | 4 | 22 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 17 | 1 | 4 | 22 |
| Trypanothione reductase | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 17 | 1 | 4 | 22 |
| Spike glycoprotein | 14 | 0 | 1 | 15 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 17 | 1 | 4 | 22 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 17 | 1 | 4 | 22 |
| Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| GABA theta subunit | 17 | 1 | 4 | 22 |
| Inositol hexakisphosphate kinase 1 | 16 | 0 | 0 | 16 |
| ATPase family AAA domain-containing protein 5 | 14 | 0 | 0 | 14 |
| Gamma-aminobutyric acid receptor subunit epsilon | 17 | 1 | 4 | 22 |
| Spermine oxidase | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 16 | 0 | 0 | 16 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Putative Glycine Betaine-binding Abc Transporter Protein | 0 | 0 | 1 | 1 |
| Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Choline-binding protein | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 4 | 0 | 4 |
| Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-9 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| High affinity choline transporter 1 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-10 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
| Chain A, Beta-lactamase | 9 | 0 | 0 | 9 |
| Chain A, Ferritin light chain | 6 | 0 | 0 | 6 |
| endonuclease IV | 5 | 0 | 0 | 5 |
| Fumarate hydratase | 5 | 0 | 0 | 5 |
| PPM1D protein | 5 | 0 | 0 | 5 |
| Thrombopoietin | 3 | 0 | 0 | 3 |
| Smad3 | 6 | 0 | 0 | 6 |
| polyprotein | 5 | 0 | 0 | 5 |
| nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
| atrial natriuretic peptide receptor 2 precursor | 4 | 0 | 0 | 4 |
| steroidogenic factor 1 | 0 | 1 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 8 | 0 | 0 | 8 |
| caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
| neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
| Tubulin alpha-1A chain | 0 | 3 | 2 | 6 |
| Tubulin beta chain | 0 | 2 | 2 | 4 |
| Plasma kallikrein | 0 | 0 | 0 | 2 |
| Tubulin beta-4A chain | 0 | 4 | 3 | 9 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
| Tubulin beta chain | 0 | 4 | 3 | 9 |
| Tubulin alpha-3C chain | 0 | 4 | 3 | 9 |
| Serine/threonine-protein kinase pim-1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 5 |
| Tubulin alpha-1B chain | 0 | 4 | 3 | 9 |
| Tubulin alpha-4A chain | 0 | 4 | 3 | 9 |
| Tubulin beta-4B chain | 0 | 4 | 3 | 9 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Tubulin beta-3 chain | 0 | 5 | 3 | 10 |
| Tubulin beta-2A chain | 0 | 4 | 3 | 9 |
| Tubulin polymerization-promoting protein | 0 | 0 | 1 | 1 |
| Tubulin beta-8 chain | 0 | 4 | 3 | 9 |
| Tubulin beta-2B chain | 0 | 3 | 1 | 6 |
| Tubulin alpha-3E chain | 0 | 4 | 3 | 9 |
| Tubulin alpha-1A chain | 0 | 4 | 3 | 9 |
| Similar to alpha-tubulin isoform 1 | 0 | 2 | 1 | 5 |
| Similar to alpha-tubulin isoform 1 | 0 | 2 | 0 | 4 |
| CREB-binding protein | 2 | 0 | 0 | 2 |
| Tubulin alpha-1C chain | 0 | 4 | 3 | 9 |
| Tubulin beta-6 chain | 0 | 4 | 3 | 9 |
| Tubulin beta-2B chain | 0 | 4 | 3 | 9 |
| Tubulin beta-1 chain | 0 | 4 | 3 | 9 |
| dopamine D1 receptor | 6 | 0 | 0 | 6 |
| regulator of G-protein signaling 4 | 16 | 0 | 0 | 16 |
| peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
| atrial natriuretic peptide receptor 1 precursor | 4 | 0 | 0 | 4 |
| M-phase phosphoprotein 8 | 8 | 0 | 0 | 8 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Phosphodiesterase | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 5 | 0 | 0 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 4 | 0 | 4 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 5 | 0 | 5 |
| GTP-binding nuclear protein Ran isoform 1 | 3 | 0 | 0 | 3 |
| Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
| Glutathione S-transferase P | 0 | 1 | 0 | 1 |
| Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 6 | 1 | 7 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Steryl-sulfatase | 0 | 0 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 2 | 1 | 6 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 3 |
| G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 4 |
| Solute carrier family 22 member 11 | 0 | 1 | 0 | 4 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 5 | 0 | 6 |
| Hsf1 protein | 0 | 0 | 2 | 2 |
| Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 3 |
| UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 4 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 3 | 0 | 4 |
| Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
| Transthyretin | 0 | 0 | 1 | 3 |
| Albumin | 0 | 2 | 3 | 5 |
| Interleukin-8 | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 14 | 0 | 15 |
| Fatty acid-binding protein, intestinal | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 4 |
| UDP-glucuronosyltransferase 2B7 | 0 | 3 | 0 | 7 |
| UDP-glucuronosyltransferase 1-6 | 0 | 3 | 0 | 4 |
| UDP-glucuronosyltransferase 1A4 | 0 | 2 | 0 | 3 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 2 |
| UDP-glucuronosyltransferase 2B10 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 10 | 0 | 10 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 3 |
| Solute carrier family 22 member 6 | 0 | 4 | 0 | 6 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 2 |
| UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 2 |
| Cereblon isoform 4 | 0 | 2 | 0 | 2 |
| Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
| Protein cereblon | 0 | 4 | 0 | 4 |
| Thromboxane A2 receptor | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 2 | 3 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
| Prostaglandin D2 receptor | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 7 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 8 | 0 | 4 | 0 | 6 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta)) | 0 | 1 | 0 | 1 |
| Trypsin | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 4 | 0 | 4 |
| Coagulation factor VII | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 2 | 0 | 2 |
| Retinoic acid receptor RXR-alpha | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
| Oxoeicosanoid receptor 1 | 0 | 1 | 0 | 1 |
| Endothelin-1 receptor | 0 | 2 | 1 | 3 |
| Tyrosine-protein kinase Fyn | 0 | 3 | 0 | 3 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 11 | 0 | 1 | 0 | 1 |
| 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 | 0 | 1 | 0 | 1 |
| Androgen receptor | 0 | 8 | 0 | 8 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 2 | 0 | 2 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 2 | 0 | 2 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C19 | 0 | 4 | 0 | 4 |
| 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 7 | 0 | 7 |
| Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
| nonstructural protein 1 | 6 | 0 | 0 | 6 |
| Cocaine esterase | 0 | 2 | 0 | 3 |
| Androgen receptor | 0 | 4 | 0 | 4 |
| Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
| Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
| Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
| Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
| Glycogen synthase kinase-3 alpha | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter A | 0 | 2 | 0 | 2 |
| Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter B(0) | 0 | 2 | 0 | 2 |
| Proton-coupled amino acid transporter 1 | 0 | 3 | 0 | 3 |
| Amino acid transporter | 0 | 2 | 0 | 2 |
| Prostacyclin receptor | 0 | 1 | 1 | 2 |
| Receptor-interacting serine/threonine-protein kinase 2 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 7 | 0 | 7 |
| Vascular endothelial growth factor receptor 2 | 0 | 2 | 0 | 2 |
| Activin receptor type-1B | 0 | 1 | 0 | 1 |
| TGF-beta receptor type-1 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
| TGF-beta receptor type-1 | 0 | 1 | 0 | 1 |
| Serum paraoxonase/arylesterase 1 | 0 | 3 | 0 | 3 |
| Caspase-1 | 0 | 1 | 0 | 1 |
| Caspase-3 | 0 | 1 | 0 | 1 |
| Caspase-4 | 0 | 1 | 0 | 1 |
| Caspase-5 | 0 | 1 | 0 | 1 |
| Caspase-9 | 0 | 1 | 0 | 1 |
| Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
| GALC protein | 4 | 0 | 0 | 4 |
| Cytochrome P450 1A1 | 0 | 2 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 5 | 7 |
| Alpha-2B adrenergic receptor | 0 | 3 | 4 | 7 |
| Alpha-2C adrenergic receptor | 0 | 3 | 4 | 7 |
| Alpha-2A adrenergic receptor | 0 | 3 | 4 | 7 |
| Alpha-1A adrenergic receptor | 0 | 4 | 5 | 11 |
| Alpha-1B adrenergic receptor | 0 | 3 | 4 | 9 |
| Beta-2 adrenergic receptor | 0 | 1 | 5 | 7 |
| Heparanase | 0 | 0 | 1 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 4 | 0 | 4 |
| Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| ClpP | 3 | 0 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 3 | 0 | 0 | 3 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 2 | 0 | 2 |
| nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 1 | 1 | 2 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 3 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 1 | 3 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 2 | 4 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 1 | 2 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 1 | 0 | 1 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 1 | 1 | 2 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
| Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 1 | 4 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 5 | 3 | 10 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 5 | 0 | 0 | 5 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 5 | 0 | 0 | 5 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 1 | 2 |
| pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
| Ornithine decarboxylase | 1 | 0 | 0 | 1 |
| Chain A, Inosine-5'-Monophosphate Dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 2 | 0 | 2 |
| Glutamate receptor 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor 3 | 0 | 1 | 0 | 1 |
| Glutamate receptor 4 | 0 | 1 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase 1 | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 2 |
| UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 4 | 0 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
| Equilibrative nucleoside transporter 1 | 0 | 1 | 0 | 1 |
| B2 bradykinin receptor | 0 | 1 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Quinolone resistance protein NorA | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 4 | 1 | 5 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
| Inositol monophosphatase 1 | 4 | 0 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 2 | 0 | 2 |
| Integrin alpha-V | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
| Apoptosis regulator Bcl-2 | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Fibroblast growth factor receptor 1 | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 4 | 0 | 4 |
| Cholecystokinin receptor type A | 0 | 3 | 1 | 4 |
| Melanocortin receptor 5 | 0 | 4 | 0 | 4 |
| Delta-type opioid receptor | 0 | 5 | 1 | 6 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Mer | 0 | 1 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| Beta-tubulin | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Nucleotide-binding oligomerization domain-containing protein 2 | 0 | 1 | 0 | 1 |
| Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 3 | 0 | 3 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 3 | 0 | 3 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 1 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 3 | 0 | 3 |
| Serine hydroxymethyltransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 3 | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 2 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 3 | 0 | 3 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 2 | 0 | 2 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 2 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 2 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase 1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase OXA-10 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 2 |
| Beta-lactamase TEM | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
| Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Efflux transporter | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Class D beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-b-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
| BlaVIM-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
| Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
| Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
| vasopressin V1b receptor | 1 | 0 | 0 | 1 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| Tumor necrosis factor | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
| Chitotriosidase-1 | 0 | 2 | 1 | 3 |
| Endochitinase B1 | 0 | 2 | 1 | 3 |
| thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
| Alpha-1B adrenergic receptor | 0 | 7 | 3 | 10 |
| Alpha-1A adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 5 | 3 | 9 |
| Histamine H1 receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 7 | 3 | 10 |
| Nischarin | 0 | 1 | 0 | 1 |
| Estrogen receptor 1 | 0 | 1 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| fMet-Leu-Phe receptor | 0 | 1 | 0 | 1 |
| Cyclooxygenase-2 | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
| Transforming growth factor beta-1 proprotein | 0 | 1 | 0 | 1 |
| Mothers against decapentaplegic homolog 3 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 4 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 1 | 2 |
| Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 4 | 1 | 6 |
| Progesterone receptor | 0 | 3 | 0 | 4 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 4 | 1 | 5 |
| Glutamate 5-kinase | 0 | 0 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 1 | 3 |
| Mu-type opioid receptor | 0 | 3 | 1 | 4 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| Kappa-type opioid receptor | 0 | 3 | 1 | 4 |
| Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 3 | 3 |
| Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
| Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
| Beta-lactoglobulin | 0 | 0 | 1 | 1 |
| Sphingosine kinase 2 | 0 | 2 | 0 | 2 |
| Sphingosine kinase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 3 | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 6 | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 7 | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 2 |
| photoreceptor-specific nuclear receptor | 0 | 1 | 0 | 1 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 0 | 0 | 2 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
| Insulin receptor | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 1 | 2 |
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
| Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
| Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
| Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
| Chain A, CES1 protein | 0 | 1 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase D3 | 0 | 1 | 0 | 1 |
| Lysosomal acid glucosylceramidase | 0 | 0 | 1 | 1 |
| Protein kinase C gamma type | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 2 | 0 | 2 |
| Protein kinase C beta type | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 1 | 2 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Procathepsin L | 0 | 0 | 1 | 1 |
| Protein kinase C delta type | 0 | 2 | 0 | 2 |
| Protein kinase C epsilon type | 0 | 2 | 0 | 2 |
| Protein kinase C zeta type | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 2 |
| Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
| Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| Protein kinase C eta type | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 4 | 0 | 4 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| B2 bradykinin receptor | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
| C-8 sterol isomerase | 0 | 2 | 0 | 2 |
| Protein kinase C iota type | 0 | 1 | 0 | 1 |
| Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
| Estrogen-related receptor gamma | 0 | 1 | 0 | 1 |
| Protein kinase C gamma type | 0 | 2 | 0 | 2 |
| Protein kinase C beta type | 0 | 2 | 0 | 2 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
| Protein kinase C theta type | 0 | 1 | 0 | 1 |
| Protein kinase C zeta type | 0 | 1 | 0 | 1 |
| Protein kinase C delta type | 0 | 1 | 0 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Platelet-activating factor acetylhydrolase | 0 | 1 | 0 | 1 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 3 | 1 | 4 |
| Serine/threonine-protein kinase D1 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 1 | 2 |
| Protein kinase C eta type | 0 | 2 | 0 | 2 |
| Emopamil-binding protein-like | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
| 7-dehydrocholesterol reductase | 0 | 1 | 1 | 2 |
| Protein kinase C theta type | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent taurine transporter | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 2 |
| Thymidine kinase, cytosolic | 0 | 2 | 0 | 4 |
| Thymidine kinase | 0 | 1 | 0 | 2 |
| Thymidine phosphorylase | 0 | 0 | 0 | 1 |
| Thymidine phosphorylase | 0 | 0 | 0 | 1 |
| Thymidylate kinase | 0 | 1 | 0 | 1 |
| Thymidine kinase, cytosolic | 0 | 0 | 0 | 2 |
| Thymidine kinase | 0 | 0 | 0 | 1 |
| Thymidylate kinase | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 2 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 0 | 0 | 1 |
| Thymidine kinase | 0 | 0 | 0 | 1 |
| procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
| NADPH oxidase 1 | 0 | 1 | 0 | 1 |
| Snq2p | 0 | 0 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| Ubiquitin carboxyl-terminal hydrolase 1 | 0 | 1 | 0 | 1 |
| Lysozyme C-1 | 0 | 1 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Calmodulin-1 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 0 | 1 | 1 |
| Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
| D(2) dopamine receptor | 0 | 2 | 1 | 3 |
| Calmodulin | 0 | 0 | 1 | 1 |
| DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
| Calcium-dependent protein kinase 4 | 0 | 1 | 0 | 1 |
| WD repeat-containing protein 48 | 0 | 1 | 0 | 1 |
| Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| Taste receptor type 2 member 14 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
| Histone deacetylase 3 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Liver carboxylesterase 1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 2 | 0 | 2 |
| Histone deacetylase 1 | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 2 | 0 | 2 |
| Histone deacetylase 2 | 0 | 2 | 0 | 2 |
| Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
| Histone deacetylase 11 | 0 | 2 | 0 | 2 |
| Histone deacetylase 8 | 0 | 2 | 0 | 2 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 2 | 0 | 2 |
| Histone deacetylase 9 | 0 | 2 | 0 | 2 |
| Histone deacetylase 5 | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Glycoprotein | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
| BRCA1 | 1 | 0 | 0 | 1 |
| P53 | 1 | 0 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
| Cyclin-T1 | 0 | 1 | 0 | 1 |
| Trypsin-1 | 0 | 1 | 0 | 1 |
| Trypsin-2 | 0 | 1 | 0 | 1 |
| Pyruvate kinase PKM | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Cyclin-A2 | 0 | 1 | 0 | 1 |
| Cyclin-C | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Trypsin-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 8 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 7 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 9 | 0 | 1 | 0 | 1 |
| Cyclin-H | 0 | 1 | 0 | 1 |
| CDK-activating kinase assembly factor MAT1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| Chain E, cAMP-dependent protein kinase, alpha-catalytic subunit | 0 | 1 | 0 | 1 |
| Chain I, cAMP-dependent protein kinase inhibitor, alpha form | 0 | 1 | 0 | 1 |
| Chain B, Rho-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Chain A, Rho-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Chain A, Rho-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | 0 | 1 | 0 | 1 |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | 0 | 1 | 0 | 1 |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | 0 | 1 | 0 | 1 |
| Chain I, cAMP-dependent protein kinase inhibitor alpha | 0 | 1 | 0 | 1 |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | 0 | 1 | 0 | 1 |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | 0 | 1 | 0 | 1 |
| Chain I, cAMP-dependent protein kinase inhibitor alpha | 0 | 1 | 0 | 1 |
| Chain A, Rho-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
| Ribosomal protein S6 kinase alpha-5 | 0 | 1 | 0 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
| C-C motif chemokine 2 | 0 | 1 | 0 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
| cAMP-dependent protein kinase catalytic subunit gamma | 0 | 1 | 0 | 1 |
| cAMP-dependent protein kinase catalytic subunit beta | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 1 | 0 | 2 | 0 | 2 |
| Serine/threonine-protein kinase N2 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |